Recombinant Pichia pastoris Probable endonuclease LCL3 (LCL3)

Shipped with Ice Packs
In Stock

Description

Characteristics of Pichia pastoris as an Expression System

Pichia pastoris offers several advantages for recombinant protein production:

  • Protein Folding and Secretion: It provides proper folding and secretion of proteins, which is crucial for maintaining biological activity .

  • Glycosylation: It performs N-linked glycosylation, which is important for therapeutic proteins, but lacks the hyperglycosylation seen in Saccharomyces cerevisiae .

  • Cost and Scalability: The cost of growth medium is low, and it can be scaled up efficiently in bioreactors .

Production and Purification of Recombinant Proteins in Pichia pastoris

The production of recombinant proteins like LCL3 in Pichia pastoris involves several steps:

  1. Cloning and Transformation: The gene encoding LCL3 is cloned into a plasmid and transformed into Pichia pastoris cells.

  2. Expression: The transformed cells are grown in a suitable medium, and the expression of LCL3 is induced, often using the AOX1 promoter.

  3. Purification: Due to the limited endogenous secretory proteins, recombinant proteins can be purified relatively easily from the culture medium .

Potential Applications of Recombinant Endonucleases

Recombinant endonucleases, such as LCL3, have potential applications in:

  • Genetic Engineering: They can be used for precise DNA editing or manipulation.

  • Biotechnology: They may be involved in the development of new biotechnological tools for DNA analysis or modification.

Table: Characteristics of Pichia pastoris Expression System

CharacteristicsPichia pastorisEscherichia coliCHO Cells
Doubling Time60–120 min30 min24 hr
Cost of Growth MediumLowLowHigh
Expression LevelLow to highHighLow to moderate
Extracellular ExpressionSecretion to mediumSecretion to periplasmSecretion to medium
Protein FoldingProper foldingRefolding usually requiredProper folding
N-linked GlycosylationHigh mannoseNoneComplex

This table highlights some of the key features of the Pichia pastoris expression system compared to other common systems .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format during order placement for guaranteed fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Our proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms maintain stability for 12 months at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The specific tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
LCL3; PAS_chr1-1_0068; Probable endonuclease LCL3
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-228
Protein Length
full length protein
Species
Komagataella phaffii (strain GS115 / ATCC 20864) (Yeast) (Pichia pastoris)
Target Names
LCL3
Target Protein Sequence
MAQSNQHVSIYNPKVIVYSIGLTTAILASMSIYRSHFVRFSTSLDVPKTLFRTKHLHGKV TSVGDGDNFHFYHLPGGIFAGWGWIRETPEINKFRKLKNKTIHVRLCGVDAPERSHFGKP SQPYSEEALQWLRQFILGKKVKVKPLSVDQYNRIVGRVFIFRWNGWNDVSEEMLRNGVAI VYENKSSAEFDGMKERYLKVENKAKKKKKGLWGIERGLTPGEYKRLYK
Uniprot No.

Target Background

Database Links
Protein Families
LCL3 family
Subcellular Location
Mitochondrion. Membrane; Single-pass membrane protein.

Q&A

What are the recommended storage conditions for recombinant LCL3?

For optimal stability, Recombinant Pichia pastoris Probable endonuclease LCL3 should be stored at -20°C for regular use, while extended storage requires conservation at -20°C or -80°C. Working aliquots may be stored at 4°C for up to one week, but repeated freezing and thawing cycles should be avoided as they can compromise protein integrity and enzymatic activity . The standard storage buffer typically consists of a Tris-based buffer with 50% glycerol, optimized specifically for this protein's stability .

How does the expression of recombinant LCL3 in Pichia pastoris compare to other expression systems?

CharacteristicsEscherichia coliPichia pastorisCHO cell
Doubling time30 min60–120 min24 hr
Cost of growth mediumLowLowHigh
Complexity of growth mediumMinimumMinimumComplex
Expression levelHighLow to highLow to moderate
Extracellular expressionSecretion to periplasmSecretion to mediumSecretion to medium
Protein foldingRefolding usually requiredRefolding may be requiredProper folding
N‐linked glycosylationNoneHigh mannoseComplex
O‐linked glycosylationNoYesYes
Phosphorylation & acetylationNoYesYes
Main drawbackAccumulation of LPSCodon biasContamination with animal viruses

This comparative analysis demonstrates why Pichia pastoris has become a preferred expression system for many complex proteins, offering a balance between proper eukaryotic post-translational modifications and relatively simple culture requirements .

What promoter systems are most effective for expressing recombinant proteins like LCL3 in Pichia pastoris?

For expressing recombinant proteins in Pichia pastoris, two primary promoter systems are available: the alcohol oxidase promoter (PAOX1) and the glyceraldehyde-3-phosphate dehydrogenase promoter (PGAP). The PAOX1 promoter is methanol-inducible and offers tight regulation but requires methanol as an inducer, while PGAP provides constitutive expression without the need for induction.

For optimal expression of LCL3-like proteins, the PAOX1 promoter is generally recommended when precise control over expression timing is required. The methanol concentration should be maintained between 0.5-2.5% (vol/vol) for maximum induction, as higher concentrations (above 5%) can be toxic to cells . While both promoters have advantages, they lack tunability, which presents a limitation in fine-tuning expression levels for proteins that may be toxic when overexpressed .

What are the most effective purification strategies for recombinant LCL3 protein?

Purification of recombinant LCL3 protein typically leverages the N-terminal 10xHis-tag incorporated into the expression construct . A methodological approach involves:

  • Affinity chromatography using nickel or cobalt resin columns to capture the His-tagged protein

  • Washing with increasing concentrations of imidazole (10-40 mM) to remove non-specifically bound proteins

  • Elution with high imidazole concentrations (250-500 mM)

  • Buffer exchange using dialysis or size exclusion chromatography to remove imidazole

  • Concentration determination using Bradford or BCA protein assays

For LCL3 specifically, when expressed in Pichia pastoris, the secretion system allows for direct purification from the culture medium, which simplifies the process compared to intracellular proteins that require cell lysis . The limited production of endogenous secretory proteins by Pichia pastoris further facilitates purification by reducing host protein contamination .

How can researchers optimize methanol induction parameters for maximum LCL3 expression in Pichia pastoris?

Optimizing methanol induction for maximum expression requires systematic fine-tuning of several parameters:

  • Methanol concentration optimization: Begin with a concentration range of 0.5-2.5% (vol/vol), testing increments of 0.5%. Concentrations up to 5% are tolerable but may impact cell viability, while concentrations below 0.5% may provide insufficient induction .

  • Feeding strategy development: Implement either:

    • Batch feeding: Add methanol every 24 hours to maintain concentration

    • Continuous feeding: Use controlled pumps to maintain constant methanol levels

    • Fed-batch strategy: Gradually increase methanol concentration as biomass increases

  • Temperature modulation: Lower cultivation temperature to 20-25°C during induction phase (from standard 30°C) to reduce proteolytic degradation and improve protein folding .

  • Induction timing: Initiate methanol induction when culture reaches late logarithmic phase (OD600 of 2-6) for optimal balance between cell density and expression efficiency.

  • Co-substrate supplementation: Consider adding sorbitol or glycerol as co-substrates during methanol induction to improve biomass generation while maintaining induction.

This methodological approach requires monitoring methanol consumption rates using gas chromatography or methanol monitoring kits to ensure optimal induction conditions are maintained throughout the expression period.

What is the predicted enzymatic mechanism of LCL3 as an endonuclease?

As a probable endonuclease (EC 3.1.-.-), LCL3 likely catalyzes the hydrolysis of internal phosphodiester bonds in nucleic acids. Based on sequence analysis and the classification as an endonuclease, LCL3 might function through a metal ion-dependent mechanism, possibly requiring divalent cations such as Mg²⁺ or Mn²⁺ as cofactors.

The catalytic domain likely recognizes specific nucleic acid structural features or sequences, positioning the phosphodiester bond for nucleophilic attack. While the exact cleavage specificity of LCL3 has not been fully characterized in the available research, the sequence contains domains consistent with nucleic acid binding and catalytic activity. Further enzymatic characterization would be required to determine substrate preference (DNA vs. RNA) and sequence specificity .

How does glycosylation affect the structure and function of proteins expressed in Pichia pastoris compared to mammalian systems?

Glycosylation patterns in Pichia pastoris differ significantly from mammalian systems, which can impact protein structure, function, and immunogenicity. The key differences include:

  • N-linked glycosylation: Pichia pastoris typically produces high-mannose type N-glycans (Man8-14GlcNAc2), which are shorter than those found in Saccharomyces cerevisiae (Man>50GlcNAc2) but still different from the complex type found in mammalian cells .

  • Absence of immunogenic epitopes: Unlike S. cerevisiae, P. pastoris does not incorporate terminal α-1,3-linked mannoses, which are known to be highly immunogenic in humans, making P. pastoris-expressed proteins more suitable for therapeutic applications .

  • O-linked glycosylation: Very limited O-linked glycosylation occurs in P. pastoris, whereas mammalian cells produce complex O-linked glycans important for protein function .

  • Knocking out the OCH1 gene (coding for α-1,6-mannosyltransferase)

  • Co-expressing human glycosylation enzymes

  • Creating strains like SuperMan5 with modified glycosylation pathways

This understanding of glycosylation differences is crucial when selecting an expression system for functionally active glycoproteins.

What bioinformatic approaches can predict potential substrates or interaction partners for LCL3?

Advanced bioinformatic approaches to predict LCL3 substrates or interaction partners include:

  • Sequence-based analysis:

    • Position-Specific Scoring Matrix (PSSM) searches to identify conserved nucleic acid recognition motifs

    • Homology modeling against known endonucleases to infer substrate specificity

    • Analysis of positively charged surface patches likely to interact with negatively charged nucleic acids

  • Structural prediction and docking:

    • AlphaFold2 or RoseTTAFold for high-confidence structural prediction

    • Molecular docking simulations with various nucleic acid substrates

    • Molecular dynamics simulations to evaluate binding stability

  • Network-based approaches:

    • Guilt-by-association analyses using co-expression data

    • Protein-protein interaction network expansion from known interactors

    • Gene ontology enrichment of potential partners to identify biological processes

  • Integrative methods:

    • Combined analysis of subcellular localization, expression patterns, and phylogenetic profiles

    • Identification of proteins co-purifying with LCL3 in affinity purification experiments

    • Cross-species conservation analysis to identify functionally important residues

These computational approaches should be followed by experimental validation through techniques such as electrophoretic mobility shift assays, protein-protein interaction studies, or nuclease activity assays with predicted substrates.

What are the optimal buffer conditions for assessing LCL3 endonuclease activity in vitro?

For in vitro assessment of LCL3 endonuclease activity, the following buffer system is recommended based on established protocols for similar endonucleases:

Basic Reaction Buffer:

  • 50 mM Tris-HCl (pH 7.5-8.0)

  • 50-100 mM NaCl or KCl

  • 5-10 mM MgCl₂ (primary divalent cation)

  • 1 mM DTT (reducing agent)

  • 0.1 mg/ml BSA (stabilizer)

Optimization variables to test:

  • pH range: 6.5-9.0 in 0.5 unit increments

  • Alternative divalent cations: MnCl₂, CaCl₂, ZnCl₂ (1-10 mM)

  • Salt concentration: 0-200 mM NaCl/KCl

  • Temperature: 25°C, 30°C, 37°C, 42°C

Standard assay procedure:

  • Prepare reaction mix with buffer and substrate (plasmid DNA, oligonucleotides, or RNA)

  • Add purified LCL3 protein at varying concentrations (10-100 nM)

  • Incubate for 30-60 minutes at optimal temperature

  • Stop reaction with EDTA (final concentration 20 mM) and loading dye

  • Analyze products by gel electrophoresis (agarose for DNA, polyacrylamide for RNA/small DNA fragments)

This methodological approach enables systematic characterization of the optimal conditions for LCL3 activity, which is essential for subsequent functional studies and applications .

How can researchers address proteolytic degradation issues when expressing LCL3 in Pichia pastoris?

Proteolytic degradation is a common challenge when expressing recombinant proteins in Pichia pastoris. For LCL3 expression, several strategic approaches can minimize this issue:

  • Strain selection: Use protease-deficient strains specifically developed to minimize proteolytic degradation:

    • SMD1163 (his4 pep4 prb1): Lacks both proteinase A and B

    • SMD1165 (his4 pep4): Lacks proteinase A

    • SMD1168 (his4 pep4): Another proteinase A-deficient strain

    • BG21 or Pichia pink: Other protease-deficient options

  • Culture optimization:

    • Reduce cultivation temperature to 20-25°C during expression phase

    • Maintain culture pH at 5.5-6.0 to reduce the activity of many proteases

    • Use casamino acids (0.5-1.0%) as competitive substrates for proteases

    • Add 1% peptone to the media as an additional protease substrate

  • Protein engineering:

    • Optimize codon usage for Pichia pastoris

    • Modify potential protease recognition sites through site-directed mutagenesis

    • Add stabilizing domains or fusion partners

  • Process adjustments:

    • Use shorter induction times with more frequent harvesting

    • Add protease inhibitors to the culture medium (e.g., PMSF, leupeptin)

    • Implement continuous product removal strategies

  • Media supplementation:

    • Add 0.1-1.0% casamino acids to serve as competing substrates

    • Supplement with yeast extract (0.5-1.0%) to provide additional nutrients

These approaches can be implemented individually or in combination to significantly reduce proteolytic degradation during LCL3 expression in Pichia pastoris .

What advanced imaging techniques can be employed to study the subcellular localization of LCL3 in yeast cells?

Understanding the subcellular localization of LCL3 requires sophisticated imaging techniques that can provide high-resolution spatial information. Several advanced methodologies are suitable for this purpose:

  • Confocal laser scanning microscopy with fluorescent protein fusions:

    • Create C- or N-terminal GFP/mCherry fusions with LCL3

    • Co-localize with established organelle markers (e.g., DAPI for nucleus, MitoTracker for mitochondria)

    • Perform time-lapse imaging to capture dynamic localization changes

    • Resolution: ~200-250 nm lateral, ~500-700 nm axial

  • Super-resolution microscopy techniques:

    • Stimulated Emission Depletion (STED): Achieves ~30-80 nm resolution

    • Photoactivated Localization Microscopy (PALM): ~20-30 nm resolution

    • Stochastic Optical Reconstruction Microscopy (STORM): ~20-30 nm resolution

    • Structured Illumination Microscopy (SIM): ~100-130 nm resolution

  • Correlative Light and Electron Microscopy (CLEM):

    • Combines fluorescence microscopy with transmission electron microscopy

    • Allows visualization of fluorescently labeled LCL3 in the context of ultrastructural details

    • Provides nanometer-scale resolution of cellular compartments

  • Expansion Microscopy:

    • Physical expansion of fixed samples using swellable polymers

    • Enables super-resolution imaging on conventional confocal microscopes

    • Achieves effective resolution of ~70 nm with 4× expansion

  • Live-cell imaging with lattice light-sheet microscopy:

    • Enables 4D imaging with minimal phototoxicity

    • Suitable for tracking LCL3 dynamics over extended periods

    • Provides ~230 nm lateral and ~370 nm axial resolution

Each technique offers different advantages in terms of resolution, sample preparation requirements, and compatibility with live-cell imaging, allowing researchers to select the most appropriate method based on their specific research questions regarding LCL3 localization and function.

How can researchers troubleshoot poor expression levels of recombinant LCL3 in Pichia pastoris?

Poor expression levels of recombinant LCL3 in Pichia pastoris can result from multiple factors. A systematic troubleshooting approach should include:

  • Genetic construct evaluation:

    • Verify correct reading frame and absence of premature stop codons

    • Check for rare codons in the LCL3 sequence and optimize if necessary

    • Ensure promoter and terminator sequences are intact

    • Confirm integration into the Pichia genome by PCR

  • Expression conditions optimization:

    • Test different methanol concentrations (0.5%, 1.0%, 1.5%, 2.0%, 2.5%)

    • Vary induction temperature (20°C, 25°C, 30°C)

    • Adjust medium pH (5.0, 5.5, 6.0, 6.5)

    • Optimize induction timing based on growth phase

  • Clone selection improvement:

    • Screen multiple transformants (10-20) for expression levels

    • Check for multi-copy integrants using qPCR

    • Perform copy number determination to correlate with expression

  • Alternative approaches:

    • Try different signal sequences (α-factor, PHO1, SUC2)

    • Switch to constitutive PGAP promoter if PAOX1 is problematic

    • Consider intracellular expression if secretion is inefficient

    • Test different Pichia strains (X-33, GS115, KM71H)

  • Process optimization:

    • Implement fed-batch fermentation instead of shake flask culture

    • Use mixed feed strategies (glycerol + methanol)

    • Supplement media with casamino acids or peptone

    • Add antifoaming agents if foaming is excessive

Each step should be documented with appropriate controls, and expression levels quantified using techniques such as SDS-PAGE, Western blotting, or enzyme activity assays to determine the most effective improvements .

What analytical methods can accurately assess the quality and activity of purified recombinant LCL3?

A comprehensive quality assessment of purified recombinant LCL3 requires multiple analytical techniques:

These methods collectively provide a comprehensive profile of LCL3 quality and activity, ensuring reproducible experimental results and reliable functional characterization.

How can researchers design advanced experiments to elucidate the biological role of LCL3 in Pichia pastoris?

Elucidating the biological role of LCL3 in Pichia pastoris requires a multifaceted experimental approach:

  • Advanced genetic manipulation strategies:

    • CRISPR/Cas9-mediated knockout of LCL3 gene

    • Creation of conditional knockdown strains using regulatable promoters

    • Site-directed mutagenesis of putative catalytic residues

    • Complementation studies with wild-type and mutant versions

  • Comprehensive phenotypic analysis:

    • Growth rate analysis under various conditions (temperature, carbon sources, stress)

    • Cell morphology examination using high-resolution microscopy

    • Cell wall integrity assays using Congo Red or Calcofluor White

    • DNA damage response assessment using UV or chemical mutagens

  • Biochemical interaction studies:

    • Tandem affinity purification (TAP) to identify protein interaction partners

    • Chromatin immunoprecipitation sequencing (ChIP-seq) to identify DNA binding sites

    • RNA immunoprecipitation (RIP) to identify RNA targets

    • Proximity-dependent biotin identification (BioID) for spatial proteomics

  • Advanced transcriptomic and proteomic analysis:

    • RNA sequencing of LCL3 knockout vs. wild-type under various conditions

    • Ribosome profiling to assess translational impacts

    • Quantitative proteomics using SILAC or TMT labeling

    • Phosphoproteomics to identify signaling pathways affected

  • Evolutionary analysis and comparative genomics:

    • Identification of LCL3 homologs in related yeast species

    • Functional complementation tests with homologs

    • Phylogenetic analysis to identify conserved functional domains

    • Comparative transcriptomics across species with and without LCL3 homologs

These advanced experimental approaches, implemented in a systematic manner, can provide comprehensive insights into the biological role of LCL3 in Pichia pastoris, potentially revealing novel functions in nucleic acid metabolism, stress response, or cellular regulation.

What emerging technologies might enhance our understanding of LCL3 function and applications?

Emerging technologies that could significantly advance our understanding of LCL3 include:

  • AlphaFold2 and RoseTTAFold structural prediction:

    • Generate high-confidence structural models of LCL3

    • Identify potential substrate binding pockets and catalytic sites

    • Guide rational design of functional mutants

    • Predict protein-protein or protein-nucleic acid interactions

  • Cryo-electron microscopy:

    • Achieve near-atomic resolution structures of LCL3 alone or in complex with substrates

    • Visualize conformational changes during catalytic cycles

    • Identify structural features unique to this class of endonucleases

  • Single-molecule techniques:

    • Fluorescence resonance energy transfer (FRET) to monitor conformational changes

    • Single-molecule tracking in live cells to observe dynamics

    • Optical tweezers to measure DNA binding and cleavage forces

  • High-throughput functional genomics:

    • CRISPR interference screens to identify genetic interactions

    • Synthetic genetic array analysis to map functional pathways

    • Pooled CRISPR screens with custom readouts for nuclease activity

  • Metabolic profiling and fluxomics:

    • Isotope labeling to track metabolic changes in LCL3 mutants

    • Integration with transcriptomics and proteomics data

    • Identification of unexpected metabolic roles

These emerging technologies, when applied to LCL3 research, promise to provide unprecedented insights into structural determinants of function, in vivo dynamics, biological roles, and potential biotechnological applications.

How might LCL3 be engineered for novel research applications in molecular biology?

Engineering LCL3 for novel research applications could follow several promising directions:

  • Substrate specificity modification:

    • Structure-guided mutagenesis to alter recognition sequences

    • Creation of programmable nucleases by fusion with sequence-specific DNA binding domains

    • Development of controllable nucleases through insertion of allosteric regulatory domains

  • Activity regulation engineering:

    • Light-inducible variants using photosensitive domains (optogenetics)

    • Chemical-inducible dimerization for temporal control

    • Temperature-sensitive variants for conditional activity

  • Cellular targeting optimization:

    • Addition of specific localization signals for compartment-specific activity

    • Creation of cell-type specific expression systems

    • Development of self-limiting constructs for transient expression

  • Detection system integration:

    • Fusion with split fluorescent proteins for activity visualization

    • FRET-based reporters of nuclease activity

    • Creation of biosensors for specific nucleic acid structures

  • Delivery method development:

    • Encapsulation in lipid nanoparticles for cellular delivery

    • Cell-penetrating peptide fusions for enhanced uptake

    • Development of self-delivering protein systems

Each of these engineering approaches could extend the utility of LCL3 beyond its natural function, potentially creating valuable tools for genome editing, synthetic biology, diagnostics, or therapeutic applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.